Objective: Geographic location may be related to the receipt of quality HIV health care services. Clinical outcomes and health care utilization were evaluated in rural, urban, and peri-urban patients seen at high-volume US urban-based HIV care sites. Methods: Zip codes for 8773 HIV patients followed in 2005 at seven HIV Research Network sites were categorized as rural (population B10,000), peri-urban (10,000Á100,000), and urban ( !100,000). Clinical and demographic characteristics, inpatient and outpatient (OP) utilization, AIDS-defining illness rates, receipt of highly active antiretroviral therapy (HAART), opportunistic infection (OI) prophylaxis usage, and virologic suppression were compared among patients, using x 2 tests for categorical variables, t-tests for means, and logistic regression for HAART utilization. Results: HIV-infected rural (n 0170) and peri-urban (n 0215) patients were less likely to be Black or Hispanic than urban HIV patients. Peri-urban subjects were more likely to report MSM as their HIV risk factor than rural or urban subjects. Age, gender, CD4 or HIV-RNA distribution, virologic suppression, HAART usage, or OI prophylaxis did not differ by geographic location. In multivariate analysis, rural and peri-urban patients were less likely to have four or more annual outpatient visits than urban patients. Rural patients were less likely to receive HAART if they were Black. Overall, geographic location (as defined by home zip code) did not affect receipt of HAART or OI prophylaxis. Conclusion: Although demographic and health care utilization differences were seen among rural, peri-urban, and urban HIV patients, most HIV outcomes and medication use were comparable across geographic areas. As with HIV care for urbandwelling patients, areas for improvement for non-urban HIV patients include access to HAART among minorities and injection drug users.
Introduction
HIV/AIDS is an increasing problem in rural areas in the United States (Berry, 2000 ; Centers for Disease Control [CDC] , 2007; Centers for Disease Control National Center for HIV, 2006; Henry J. Kaiser Family Foundation, 2007; Karon, Fleming, Steketee, & De Cock, 2001) , and the epidemiology of HIV/AIDS in rural America differs from that of other geographic areas (CDC, 2007; Ellerbrock et al., 1992; Karon et al., 2001 ; Rural Center for AIDS/STD Prevention, 2009; Wasser, Gwinn, & Fleming, 1993; Whyte & Carr, 1992; Young, Feldman, Brackin, & Thompson, 1992) . Small localized studies in rural areas have demonstrated higher proportions of women, fewer injection drug users (IDUs), and more heterosexual transmission of HIV than in urban areas. These populations may be less likely to receive quality of care, and this may be associated with suboptimal HIV outcomes (Anderson & Mitchell, 2000; Asch et al., 2001; Gebo, Fleishman, Conviser et al., 2005; Lucas, Cheever, Chaisson, & Moore, 2001; McNaghten, Hanson, Dworkin, & Jones, 2003; Shapiro et al., 1999; Solomon et al., 1998; Stein et al., 1991; Teshale et al., 2007) .
Compared with persons living with HIV/AIDS in urban areas, rural residents are are diagnosed in later stages of illness (Calonge, Petersen, Miller, & Marshall, 1993; Miller et al., 1995) , are less likely to have health insurance (Hu, Duncan, Radcliff, Porter, & Hall, 2006; Ricketts, 2000) , and frequently travel over 2 hours to receive care (Mainous & Matheny, 1996) , especially to urban sites (Schur et al., 2002) . Schur et al. (2002) found that over 25% of surveyed rural HIV patients delayed HIV care because they lacked reliable transportation to their provider. Other barriers to receiving HIV services in rural areas include stigma, physician shortages/inexperience, and a lack of community education and social support (Centers for Disease Control and Prevention, 1998; Graham, Forrester, Wysong, Rosenthal, & James, 1995; Hall, Li, & McKenna, 2005; Mainous & Matheny, 1996; McKinney, 2002; Miller et al., 1995; Ricketts, 2000; Schur et al., 2002; Williams, Bowen, & Horvath, 2005) .
This study examines the impact of geographic categorization of home zip code on clinical HIV outcomes, using data from a multisite, multistate cohort in the era of highly active antiretroviral therapy (HAART).
Methods

Setting and subjects
The HIV Research Network is a consortium of 21 sites that provide primary and subspecialty care to HIV patients Gebo, Fleishman, Conviser et al., 2005; . To be included, a site must have a minimum data-set available in electronic format or through paper abstraction. The minimum data required were patients' age, sex, race, HIV transmission risk factor, AIDS-defining illnesses, CD4 level, HIV-1 RNA, and antiretroviral medication use. This analysis was limited to adult patients (]18 years old) in HIV primary care, defined by at least one visit to an HIV primary care provider and one recorded CD4 test result during the calendar year 2005.
Seven sites that collect zip code information and provide care to patients residing in rural areas were included in the analysis. The five academic sites and two community-based sites were located in the northeastern (1), western (2), midwestern (2), and southern (2) US. The median sample size per site was 665 patients (range: 55Á3456 patients). Zip codes from 8824 HIV patients followed in 2005 at these seven HIV Research Network sites were categorized via the University of Washington rural health categorization schema as rural ( B10,000 population), peri-urban (10,000Á100,000), and urban (!100,000; Hart, Larson, & Lishner, 2005; WWAMI Rural Health Research Center, 2008) . Of note, all the study sites in the analysis are located in urban areas. Although some patients in one site did receive care at rural locations by providers traveling from urban academic health centers, the majority received care at the urban study sites. While rural dwellers may receive care in the same urban clinic setting as their urban/peri-urban counterparts, they potentially may receive different care in these clinics, due to less frequent care utilization. Reasons for less frequent care utilization may include transportation issues and distance-related factors such as decreased social services, lack of childcare services, financial constraints, and fewer social networks. Thus, this study analyzes urban, peri-urban, and rural dwellers receiving HIV specialty care in predominantly urban clinics.
Data collection
The data elements described in the preceding section were abstracted from electronic or paper records at each site. Abstracted data were sent in electronic format to a data-coordinating center after personal identifying information was removed. For this analysis, data collection encompassed calendar year 2005. The date of the encounter was used. Electronic data received by the coordinating center were reviewed to ensure that each data element was correctly formated and that all elements were captured. Data elements with incorrect formating, unknown or incomplete information, or other inaccuracies were reviewed with the site and corrected. After this verification process, the data were combined across sites to achieve a uniformly constructed multisite database. A variable identifying the site was included in the database. The study was approved by the Institutional Review Board of the Johns Hopkins School of Medicine as well as by each of the participating sites.
Definitions of variables
HAART was defined as use of (1) 3 and HIV-1 RNA 0400 copies/mL). HIV transmission risk factors included injection drug use (IDU), men who had sex with men (MSM), and heterosexual transmission (HET), which was defined as either heterosexual activity with a partner at high risk for HIV or sex with an HIV-infected individual. Risk factor assignment was not mutually exclusive, as patients could have multiple HIV risk factors.
For purposes of analysis, we classified patients as IDU or non-IDU; the IDU category included patients with other risk factors (i.e., MSM or HET) in addition to IDU. Adequate outpatient utilization was defined as four or more visits in a calendar year, consistent with the International AIDS Society-United States of America (IAS-USA) guidelines that recommend at least quarterly visits for HIV-infected patients.
Insurance was categorized into private, Medicaid, Medicare, self-pay/Ryan White, and other. A small number of patients with dual Medicare/Medicaid coverage were classified as Medicare, as Medicare is the primary payer for these patients. In the analysis, we classified patients as private versus other, which included all public insurance as well as self-pay/Ryan White Care Act coverage.
Data analysis
We conducted descriptive analyses of geographic variation in demographic and clinical characteristics, including age, gender, race/ethnicity (White, Black, Hispanic, and Other), HIV risk factors, CD4 count (B50, 51Á200, 201Á350 351Á500, !500 cells/mm 3 ), HIV-1 RNA ( B10,000, 10,000Á100,000, !100,000 copies/mL), use of HAART, opportunistic infection (OI) prophylaxis, development of an AIDS-defining illness (ADI), insurance coverage, and inpatient and outpatient utilization. For multivariate analyses, race/ethnicity was collapsed into Black, Hispanic, and White. Asian, Native American, and Other race categories were collapsed into the White category because of small sample sizes. The mean and standard deviation were used for describing normally distributed data, whereas the median and interquartile ranges were used for describing non-normally distributed data. Normally distributed continuous variables were analyzed with Student's t-test; the Wilcoxon rank-sum test was used for analysis of nonnormal data. Categorical variables were analyzed with Fisher's exact test. ANOVA was used to test three-way measures. Statistical analyses were done with STATA 10.0 (College Station, TX).
In bivariate analyses, we examined geographic differences in the number of outpatient visits, development of an ADI, receipt of HAART (among those with CD4 B350 cells/mm 3 ), and receipt of OI prophylaxis (among those for whom it was clinically appropriate). For variables with (unadjusted) geographic differences in bivariate analyses, we used multivariate logistic regression to estimate geographic differences, adjusted for other significant variables. Transgendered persons (n051) were not included in the multivariate analysis. All reported p values are two-sided.
Results
Demographic and clinical characteristics
Compared to urban patients, rural and peri-urban HIV-infected patients were significantly less likely to be Black (22% and 21% vs. 40%, p B0.001) or Hispanic (11% and 14% vs. 20%, pB0.001) and more likely to be White (65% and 62% vs. 37%, pB0.001; Table 1 ). Rural and peri-urban patients did not differ from urban patients by age or gender. The median age was 42 years (range: 18Á95 years) in all (Table 2) . Similarly, median HIV-1 RNA (rural 0440 copies/ mL, peri-urban 0400 copies/mL, urban0490 copies/ mL) and distribution of HIV-1 RNA were similar between the groups. Likewise, rates of HIV virologic suppression for patients receiving HAART did not differ between rural (58%), peri-urban (64%), and urban (60%) residence. Although rates of ADIs were lower among peri-urban than among rural and urban patients (0.5/100 PY [person-years] vs. 5.3/100 PY and 2.4/100 PY), these differences were not statistically significant ( p00.17; Table 2 ).
Health care utilization
Overall, rural and peri-urban patients had fewer outpatient visits than urban patients (3.95 visits per patient per year [PPPY] and 4.04 visits vs. 5.24 visits, pB0.001; Table 3 ). Of those on HAART, rural patients had fewer visits than peri-urban or urban patients (4.02 vs. 4.48 vs. 5.83 visits/PPPY, pB0.001). The rate of inpatient admissions was higher among urban residents (26.8 per 100 PY) than among rural and peri-urban residents (17.1 and 16.3 admissions per 100 PY, respectively). In patients with a clinical indication, pharmaceutical utilization rates of prophylaxis for Pneumocystis jiroveci pneumonia (PCP) and Mycobacterium avium complex (MAC) were uniformly high and did not differ by residential location.
In bivariate analysis ( Because residential differences in HAART receipt were close to being statistically significant, we further explored the data via multivariate logistic regression analyses. Adjusting for other variables did not substantially alter the magnitude or statistical significance of geographic differences in the odds of receiving HAART ( 
Discussion
In this study, persons living with HIV/AIDS in rural and peri-urban areas who received care in urban areas experienced high levels of appropriate OI prophylaxis and favorable HIV outcomes (i.e., virologic suppression, incidence of ADIs), comparable to those living in urban areas. Unexpectedly, the unadjusted proportion of eligible patients receiving HAART was actually somewhat higher for non-urban patients than for urban patients. Also, outpatient utilization was lower among HIV-infected rural patients, compared to urban patients. Finally, HIV-infected patients from non-urban areas followed in this observational cohort are less likely to be Black or Hispanic than HIV-infected urban patients but were otherwise demographically similar.
Rural and peri-urban patients in this study had high rates of HAART utilization and OI prophylaxis that were consistent with national guidelines (Yeni et al., 2004) . Most rural and peri-urban patients in this population traveled to urban tertiary centers to receive care. In addition, previous work has demonstrated that when providers from urban centers travel to deliver care in rural areas, high-quality HIV care can also be achieved (Wilson et al., 2006) . Thus, elimination of access barriers may contribute to an improvement in quality of care for rural HIV residents. In contrast, studies from the pre-HAART era that reported sub-standard HIV care for rural patients (Calonge et al., 1993; Miller et al., 1995; Whyte & Carr, 1992) primarily dealt with HIV patients who received care in rural areas. Future studies will need to examine whether patients who receive their care at local, rural, or peri-urban settings have different outcomes than those who travel to urban high-volume HIV care centers.
Rural and peri-urban patients had less frequent outpatient utilization than urban patients overall, as well as among those on HAART therapy. This raises concern about the quality of HIV monitoring in nonurban patients on HAART. However, rural and periurban patients on HAART still met International AIDS Society HIV-USA Panel treatment guidelines (Yeni et al., 2004 ) by having at least quarterly AIDS Care 975 visits with their providers and were as likely to achieve virologic suppression. Interestingly, rural and peri-urban patients also had lower inpatient utilization rates than urban patients, although these rates were not different if patients were taking HAART. While observed geographic differences may be due to patients' seeking care outside of the HIV Research Network, all sites make an effort to comprehensively record inpatient utilization by patients at both their sites and outside medical facilities. Consistent with previous literature demonstrating that patients affected by HIV in rural areas differ from those in urban areas (Cohn et al., 2001; Ellerbrock et al., 1992; Rural Center for AIDS/STD Prevention, 2009; Wasser et al., 1993; Young et al., 1992) , we found that non-urban patients were more likely to be White than urban patients; however, unlike previous studies, we found no differences in the prevalence of IDU by geographic distribution. Otherwise, in this multisite, multistate cohort, there were few demographic differences between rural and urban patients, other than increased MSM HIV risk factor among peri-urban patients.
Like previous studies, our results demonstrate that IDUs were less likely to receive HAART than non-IDUs, and those engaged in longitudinal care (four or more visits per year) were more likely to receive HAART than those who were not in care. Of note, those with private insurance were less likely to receive HAART than those with governmental assistance or no insurance. This may reflect the utilization of the AIDS Drug Assistance Programs (ADAP), which provide access to medications for HIV-infected patients. Rules for eligibility for these programs and drugs covered vary from state to state. Future studies will need to evaluate changes in HAART utilization with changes in our health care delivery system.
There are several potential study limitations. Our study population is not nationally representative and may not generalize to all HIV-infected Americans. However, sites from which patients were sampled do encompass a broad geographic distribution, and multisite studies afford greater generalizability than single-site studies. In addition, providers at these sites are highly experienced in HIV care with high rates of HAART usage (Gebo, Fleishman, Conviser et al., 976 L.E. Wilson et al. 2005 ) and OI prophylaxis among their patients. Therefore, our results may not generalize to patients receiving care from providers with less HIV experience, as may be typical in a rural/peri-urban clinic with lower HIV patient volume. As the data collected were on patients actively engaged in primary care, we were unable to capture individuals not engaged in primary HIV care, incarcerated, or unaware of their HIV diagnosis. HIV-infected patients who are not in primary care may be significantly different from those who engage in HIV care. Also, it must be acknowledged that ''rural'' and ''peri-urban'' do not depict uniform demographic or geographic entities but rather many unique regions within the United States with lower population density. Additionally, we were unable to analyze the distance traveled by each patient to determine whether quality of HIV care was related to distance traveled, as de-identified data made it impossible to match geographic location with HIV care site. HIV patients who reside in non-urban areas but receive care in urban areas may not be representative of the full population of non-urban patients with HIV infection. They may have more economic or social resources, or they may have more motivation to seek high-quality care than other non-urban dwellers. Such factors might explain why non-urban residents in this study had higher odds of receiving HAART than urban dwellers. As we did not have access to a large number of rural HIV patients accessing HIV care in rural locations, future studies will need to assess this topic further. In summary, this study demonstrates that, despite demographic and geographic differences between urban, rural, and peri-urban HIV patients followed in the HIV Research Network, it is possible to provide high-quality HIV care to non-urban residents. With care from providers with extensive HIV clinical expertise, these patients had high rates of OI prophylaxis and HAART usage. Given the increasing prevalence of HIV in non-urban areas in the United States, future studies will need to examine care provided by providers located in non-urban settings to confirm the results of this study.
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